Ala. High Court Upholds Landmark Generic-Drug Injury Ruling

By Kira Lerner (August 15, 2014, 6:12 PM EDT) -- The Alabama Supreme Court on Friday upheld its decision finding that makers of brand-name drugs can be held liable for injuries caused by their generic counterparts, a ruling that Pfizer Inc. called an "outlier" among the courts. 

After agreeing to reconsider the case in June 2013, the state's high court issued a divided opinion with five justices agreeing to uphold the court's January 2013 order finding that under state law, consumers allegedly injured by a generic drug can bring suit against the corresponding brand-name manufacturer for fraud or misrepresentation based on statements it made about the brand-name drug, such as those...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!